Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 2, 2017

View Archived Issues

Discovery of a novel orally bioavailable HSF1 pathway inhibitor, CCT-251236

miRNAs identified as regulators of intestinal epithelial barrier function in IBS-D

Allergy Therapeutics reports preclinical findings on Polyvac Peanut

Pfizer descirbes new PI3Kalpha inhibitors

The University of Texas, Loyola University Chicago identify novel dimetalloenzymes inhibitors

Galapagos and AbbVie present CFTR channel correctors

Roche divulges novel mGlu4 positive allosteric modulators

Researchers from FAU and Sancilio collaborate to develop treatment for retinitis pigmentosa

Takeda presents new histone deacetylase inhibitors

Oncology Venture Sweden announces status update on its oncology pipeline

InFlectis BioScience forms strategic partnership in ophthalmology

Pfizer profiles pipeline progress of fourth quarter 2016

Alzamend Neuro licenses USF immunotherapeutic treatment for Alzheimer's

EA Pharma submits NDA in Japan for elobixibat

FDA grants rare pediatric disease designation to NS-065

EMA grants BioMarin's BMN-270 for hemophilia A access to PRIME initiative

Allergan completes acquisition of LifeCell

Novo Nordisk and University of Oxford collaborate on discovery of innovative therapies

Meridian Laboratories and Apobiologix sign definitive agreement for docetaxel injection

FDA grants hydroxypioglitazone orphan drug status for the treatment of X-linked adrenoleukodystrophy

Vixotrigine given FDA orphan drug designation for erythromelalgia

New B-SMART project to develop RNA-based therapy for neurodegenerative diseases

miRNAs as biomarkers of response to stem cell therapy in rheumatoid arthritis

Chugai Pharmaceutical highlights progress of fourth quarter 2016

NCI grant supports Personal Genome Diagnostics' development of MutatorDETECT

MeiraGTx receives grant for gene therapy for ALS

Targovax reports survival data from first cohort of phase I/II study of TG-01 in pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...